MUDr. Tomas Edelsberger

Krnov 79401

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Diseases, Chronic Kidney Disease, Dyslipidemia, Obesity, Overweight, Overweight or Obesity, Type 1 Diabetes, Type 2 Diabetes, Type2 Diabetes

Studies at this site

• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes — Recruiting now
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight — Running, not enrolling
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early